These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22682129)

  • 1. Genetic pathways linking hemostasis and cancer.
    Garnier D; Magnus N; D'Asti E; Hashemi M; Meehan B; Milsom C; Rak J
    Thromb Res; 2012 Apr; 129 Suppl 1():S22-9. PubMed ID: 22682129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic determinants of cancer coagulopathy, angiogenesis and disease progression.
    Rak J; Klement P; Yu J
    Vnitr Lek; 2006 Mar; 52 Suppl 1():135-8. PubMed ID: 16637463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the tissue factor pathway in the biology of tumor initiating cells.
    Garnier D; Milsom C; Magnus N; Meehan B; Weitz J; Yu J; Rak J
    Thromb Res; 2010 Apr; 125 Suppl 2():S44-50. PubMed ID: 20434004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue factor and cancer stem cells: is there a linkage?
    Milsom C; Magnus N; Meehan B; Al-Nedawi K; Garnier D; Rak J
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2005-14. PubMed ID: 19628788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological basis of personalized anticoagulation in cancer: oncogene and oncomir networks as putative regulators of coagulopathy.
    D'Asti E; Rak J
    Thromb Res; 2016 Apr; 140 Suppl 1():S37-43. PubMed ID: 27067976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenes and the coagulation system--forces that modulate dormant and aggressive states in cancer.
    Magnus N; D'Asti E; Meehan B; Garnier D; Rak J
    Thromb Res; 2014 May; 133 Suppl 2():S1-9. PubMed ID: 24862126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain neoplasms and coagulation.
    Magnus N; D'Asti E; Garnier D; Meehan B; Rak J
    Semin Thromb Hemost; 2013 Nov; 39(8):881-95. PubMed ID: 24108471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of tumor-and host-related tissue factor pools in oncogene-driven tumor progression.
    Milsom C; Yu J; May L; Meehan B; Magnus N; Al-Nedawi K; Luyendyk J; Weitz J; Klement P; Broze G; Mackman N; Rak J
    Thromb Res; 2007; 120 Suppl 2():S82-91. PubMed ID: 18023719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular determinants of cancer stem cell dormancy--do age and coagulation system play a role?
    Rak J; Milsom C; Yu J
    APMIS; 2008; 116(7-8):660-76. PubMed ID: 18834410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenes, trousseau syndrome, and cancer-related changes in the coagulome of mice and humans.
    Rak J; Yu JL; Luyendyk J; Mackman N
    Cancer Res; 2006 Nov; 66(22):10643-6. PubMed ID: 17108099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic basis of thrombosis in cancer.
    D'Asti E; Magnus N; Meehan B; Garnier D; Rak J
    Semin Thromb Hemost; 2014 Apr; 40(3):284-95. PubMed ID: 24599437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue factor and cancer.
    Milsom C; Rak J
    Pathophysiol Haemost Thromb; 2008; 36(3-4):160-76. PubMed ID: 19176989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue factor in cancer and angiogenesis: the molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy.
    Rak J; Milsom C; May L; Klement P; Yu J
    Semin Thromb Hemost; 2006 Feb; 32(1):54-70. PubMed ID: 16479463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diverse roles of tissue factor-expressing cell subsets in tumor progression.
    Milsom C; Yu J; May L; Magnus N; Rak J
    Semin Thromb Hemost; 2008 Mar; 34(2):170-81. PubMed ID: 18645922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenes as regulators of tissue factor expression in cancer: implications for tumor angiogenesis and anti-cancer therapy.
    Yu JL; May L; Klement P; Weitz JI; Rak J
    Semin Thromb Hemost; 2004 Feb; 30(1):21-30. PubMed ID: 15034795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses.
    Morel O; Morel N; Freyssinet JM; Toti F
    Platelets; 2008 Feb; 19(1):9-23. PubMed ID: 18231934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemostatic factors, innate immunity and malignancy.
    Degen JL; Palumbo JS
    Thromb Res; 2012 Apr; 129 Suppl 1():S1-5. PubMed ID: 22682116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue factor proangiogenic signaling in cancer progression.
    Schaffner F; Yokota N; Ruf W
    Thromb Res; 2012 Apr; 129 Suppl 1():S127-31. PubMed ID: 22682123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crosstalk between cancer and haemostasis. Implications for cancer biology and cancer-associated thrombosis with focus on tissue factor.
    Langer F; Bokemeyer C
    Hamostaseologie; 2012; 32(2):95-104. PubMed ID: 21792469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue factor in tumour progression.
    Rak J; Milsom C; Magnus N; Yu J
    Best Pract Res Clin Haematol; 2009 Mar; 22(1):71-83. PubMed ID: 19285274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.